UCI statement on Fabio Taborre and UCI Professional Continental Team Androni Giocattoli-Sidermec

The Union Cycliste Internationale (UCI) announces that it has notified Italian rider Fabio Taborre ofan Adverse Analytical Finding (AAF) of FG-4592 (*) in a sample collected during an out-of-competitiontest on 16 June 2015.

The rider has the right to request and attend the analysis of the B sample.

In accordance with UCI Anti-doping Rules (UCI ADR), the rider has been provisionally suspended untilthe adjudication of the affair.

This constitutes the second AAF for a member of the UCI Professional Continental TeamAndroni Giocattoli-Sidermec (**) since the beginning of 2015 and within a twelve-month period.Therefore article 7.12.1 UCI ADR providing for the suspension of the Team from 15 to 45 days (***)will be applied.

The UCI will refer the matter to the Disciplinary Commission which will render a decision in theupcoming days.

At this stage of the procedure, the UCI will not comment any further on any of these matters.

(*) FG-4592 is a prohibited substance that has the property of stimulating the endogenous production of EPO.

(**) On 30 June 2015, the UCI Professional Continental Team Androni Giocattoli-Sidermec Italian rider Davide Appolloniowas notified of an AAF of EPO in a sample collected during an out-of-competition test on 14 June 2015.

(***) Article 7.12.1 UCI ADR which entered into force on 1 January 2015.

For more information, contact:

Louis Chenaille

UCI Press Officer

+41 79 198 7047

louis.chenaille@uci.ch

John Zerafa

VERO Communications

+44 7813 814 816

jzerafa@verocom.co.uk

20 Years at #1: Your best source of news about the Olympics is www.aroundtherings.com, for subscribers only